Nadine Brew

Nadine Brew is an Investor at Brandon Capital Partners and a Business Development Manager at the Hudson Institute of Medical Research, based in Melbourne, Victoria, Australia. She previously served as the General Manager at Cincera Therapeutics and spent over a decade conducting biomedical research across academic laboratories in Australia and the United States. Brew holds a PhD in Developmental Physiology from Monash University and serves on the investment committee for the Monash-Breakthrough Victoria Pre Seed Fund. As an advocate for female leadership in the life sciences sector, she co-founded the WILD Program, an initiative that secured $1 million in federal funding in August 2021 to support women in STEM. Her current professional focus centers on early-stage biotechnology investments, drug development across multiple therapeutic modalities, and translating university intellectual property into viable commercial life sciences enterprises.